What We’re Still Getting Wrong in Cancer Care — Glaring Gaps in the Face of Astonishing Advancements

Amidst the distress caused by a cancer diagnosis, patients are left to sort through vast amounts of information, treatment options, and concerns around efficacy and side effects, while juggling other life activities. The post What We’re Still Getting Wrong in Cancer Care — Glaring Gaps in the Face of Astonishing Advancements appeared first on MedCity…

Read More

AstraZeneca Expands Cardiovascular Disease Prospects, Paying $100M for Oral Way to Drug Lp(a)

Cardiovascular disease drugs in development intended to reduce lipoprotein (a) are mostly injectable medications, though Eli Lilly also has both oral and injectable drugs in the clinic. AstraZeneca aims to hit that key protein target with an oral small molecule licensed from CSPC Pharmaceutical Group. The post AstraZeneca Expands Cardiovascular Disease Prospects, Paying $100M for…

Read More